Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

Clinical trial NCT01054170 · COMPLETED

Trial details

NCT number: NCT01054170
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2010-01-01
Primary completion: 2010-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.